Rezolute, Inc. (RZLT)
3.13
-0.08
(-2.49%)
USD |
NASDAQ |
Mar 02, 16:00
3.13
0.00 (0.00%)
After-Hours: 20:00
Rezolute Research and Development Expense (Annual) : 61.53M for June 30, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Pfizer Inc. | 10.25B |
| Geron Corp. | 73.72M |
| XOMA Royalty Corp. | 2.875M |
| CorMedix, Inc. | 3.942M |
| Sarepta Therapeutics, Inc. | 1.496B |